217 related articles for article (PubMed ID: 36211362)
1. Desmoglein compensation hypothesis fidelity assessment in Pemphigus.
Sielski L; Baker J; DePasquale MC; Attwood K; Seiffert-Sinha K; Sinha AA
Front Immunol; 2022; 13():969278. PubMed ID: 36211362
[TBL] [Abstract][Full Text] [Related]
2. Two cases of cutaneous-type pemphigus vulgaris and a case of pemphigus foliaceus without mucosal involvement despite high anti-desmoglein 3 autoantibody levels.
Terada A; Akasaka E; Nakano H; Sawamura D
J Dermatol; 2023 Nov; 50(11):1501-1505. PubMed ID: 37485682
[TBL] [Abstract][Full Text] [Related]
3. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
[TBL] [Abstract][Full Text] [Related]
4. Anti-Desmoglein 1 and 3 Autoantibody Levels in Endemic Pemphigus Foliaceus and Pemphigus Vulgaris from Brazil.
Oliveira LA; Marquart-Filho A; Trevilato G; Timoteo RP; Mukai M; Roselino AM; Petzl-Erler ML
Clin Lab; 2016 Jul; 62(7):1209-1216. PubMed ID: 28164651
[TBL] [Abstract][Full Text] [Related]
5. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.
Amagai M; Tsunoda K; Zillikens D; Nagai T; Nishikawa T
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):167-70. PubMed ID: 10025740
[TBL] [Abstract][Full Text] [Related]
6. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
[TBL] [Abstract][Full Text] [Related]
7. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
[TBL] [Abstract][Full Text] [Related]
8. Ca
Schmitt T; Egu DT; Walter E; Sigmund AM; Eichkorn R; Yazdi A; Schmidt E; Sárdy M; Eming R; Goebeler M; Waschke J
Br J Dermatol; 2021 Sep; 185(3):595-604. PubMed ID: 33792909
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with non-pathogenic antibodies against desmoglein-3 in pemphigus foliaceus.
Vernal S; Julio TA; Alves FH; Turatti A; Donadi EA; Roselino AM
An Bras Dermatol; 2024 Jun; ():. PubMed ID: 38851894
[TBL] [Abstract][Full Text] [Related]
10. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
Hashimoto T; Amagai M; Garrod DR; Nishikawa T
Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T
Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707
[TBL] [Abstract][Full Text] [Related]
12. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype.
Harman KE; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
Br J Dermatol; 2000 Aug; 143(2):343-8. PubMed ID: 10951143
[TBL] [Abstract][Full Text] [Related]
13. The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient.
Ivars M; España A; Alzuguren P; Pelacho B; Lasarte JJ; López-Zabalza MJ
Br J Dermatol; 2020 May; 182(5):1194-1204. PubMed ID: 31370093
[TBL] [Abstract][Full Text] [Related]
14. IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis.
Oktarina DA; van der Wier G; Diercks GF; Jonkman MF; Pas HH
Br J Dermatol; 2011 Sep; 165(3):552-62. PubMed ID: 21692763
[TBL] [Abstract][Full Text] [Related]
15. Case report: Documentation of cutaneous only pemphigus vulgaris without history of mucosal lesions in North America.
Baker J; Seiffert-Sinha K; Sinha AA
Front Immunol; 2022; 13():969279. PubMed ID: 36159821
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against Desmoglein 1 and 3 in South Tunisian pemphigus.
Jerbi A; Hachicha H; Feki S; Abida O; Bahloul E; Sellami K; Bouzid A; Turki H; Masmoudi A; Masmoudi H
Tunis Med; 2021 Octobre; 99(10):992-999. PubMed ID: 35288901
[TBL] [Abstract][Full Text] [Related]
17. Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus.
Walter E; Vielmuth F; Rotkopf L; Sárdy M; Horváth ON; Goebeler M; Schmidt E; Eming R; Hertl M; Spindler V; Waschke J
Sci Rep; 2017 Jun; 7(1):3579. PubMed ID: 28620161
[TBL] [Abstract][Full Text] [Related]
18. Using desmoglein 1 and 3 enzyme-linked immunosorbent assay as an adjunct diagnostic tool for pemphigus.
Huang CH; Chen CC; Wang CJ; Chang YT; Liu HN
J Chin Med Assoc; 2007 Feb; 70(2):65-70. PubMed ID: 17339147
[TBL] [Abstract][Full Text] [Related]
19. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus.
Adaszewska A; Kalinska-Bienias A; Jagielski P; Wozniak K; Kowalewski C
J Immunol Methods; 2019 May; 468():35-39. PubMed ID: 30910537
[TBL] [Abstract][Full Text] [Related]
20. Five Japanese cases of antidesmoglein 1 antibody-positive and antidesmoglein 3 antibody-negative pemphigus with oral lesions.
Koga H; Ohyama B; Tsuruta D; Ishii N; Hamada T; Dainichi T; Natsuaki Y; Sogame R; Fukuda S; Karashima T; Tada J; Yamashiro M; Uezato H; Chan PT; Hashimoto T
Br J Dermatol; 2012 May; 166(5):976-80. PubMed ID: 22242828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
